Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Home

Showing results (11-20 of 231) with videos related to

Pageof 24
Sort By:
Pharmacoeconomics|December 9, 1994
Pharmacoeconomics of diabetes surveillance and detection programmesP D Home
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1995
[Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes]P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
HbA(1c): the case for using estimated average glucose (eAG)P D Home
Diabetes, Obesity & Metabolism|December 3, 2014
A common fallacy of observational medication studies in diabetesP D Home
Diabetes, Obesity & Metabolism|February 28, 2001
Postprandial hyperglycaemia: mechanisms and importanceP D Home
BMJ (Clinical Research Ed.)|March 5, 1994
Diagnosing the undiagnosed with diabetesP D Home
Diabetes Care|June 27, 2013
Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Philip D Home
Journal of the Royal College of Physicians of London|January 1, 1988
Techniques for ensuring that your next paper is quite unsuitable for publicationP D Home
Diabetes, Obesity & Metabolism|March 4, 2025
An overview of insulin therapy for the non-specialistPhilip D Home
Diabetic Medicine : a Journal of the British Diabetic Association|October 26, 2000
Rapid-acting insulin analogues: when randomized clinical trial results do not helpP D Home
Pageof 24

Showing results (11-20 of 231) with videos related to

Sort By:
Pageof 24
Pharmacoeconomics|December 9, 1994
Pharmacoeconomics of diabetes surveillance and detection programmesP D Home
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1995
[Respective contributions of the method of insulin injection and its absorption by subcutaneous route in the etiopathogenesis of unstable diabetes]P D Home
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
HbA(1c): the case for using estimated average glucose (eAG)P D Home
Diabetes, Obesity & Metabolism|December 3, 2014
A common fallacy of observational medication studies in diabetesP D Home
Diabetes, Obesity & Metabolism|February 28, 2001
Postprandial hyperglycaemia: mechanisms and importanceP D Home
BMJ (Clinical Research Ed.)|March 5, 1994
Diagnosing the undiagnosed with diabetesP D Home
Diabetes Care|June 27, 2013
Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147Philip D Home
Journal of the Royal College of Physicians of London|January 1, 1988
Techniques for ensuring that your next paper is quite unsuitable for publicationP D Home
Diabetes, Obesity & Metabolism|March 4, 2025
An overview of insulin therapy for the non-specialistPhilip D Home
Diabetic Medicine : a Journal of the British Diabetic Association|October 26, 2000
Rapid-acting insulin analogues: when randomized clinical trial results do not helpP D Home
Pageof 24